Perforin-independent CD8+ T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-α -: Relative insensitivity to Fas ligand

被引:79
|
作者
Liu, AN
Mohammed, AZ
Rice, WR
Fiedeldey, DT
Liebermann, JS
Whitsett, JA
Braciale, TJ
Enelow, RI
机构
[1] Univ Virginia, Sch Med, Berine B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA
[2] Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA
[3] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA
[4] Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA
[5] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA
关键词
D O I
10.1165/ajrcmb.20.5.3585
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD8(+) T cells appear to play an important pathophysiologic role in many inflammatory lung diseases. The primary effector function of this T-cell subset is cytolysis of virus-infected cells, and it is widely believed that there are two primary molecular mechanisms by which this occurs: the perforin/granzyme-mediated pathway of cytolysis, and the Fas ligand (FasL)-Fas (CD95/APO-1) pathway of induction of target-cell apoptosis. This conclusion is based primarily on data obtained with hematopoetic cell lines as target cells. There is also a growing body of evidence that Fas is involved in the transduction of apoptotic signals in a variety of inflammatory disease states, particularly involving the liver and the lung. In the study reported here we took advantage of a novel in vitro assay to directly assess the effector mechanisms employed in CD8(+) T-cell-mediated cytolysis of alveolar epithelial cells. We present evidence that Fast-induced, Fas-mediated apoptosis does not directly contribute to T-cell-mediated cytolysis of alveolar epithelial-derived cells, even though Fas is expressed and functional on these cells. We also demonstrated that the perforin-independent cytolytic activity of CD8(+) T cells against alveolar epithelial-derived cells is explained entirely by tumor necrosis factor-alpha (TNF-alpha), which is expressed on CD8(+) T cells. Furthermore, we show that bystander cytolysis of alveolar epithelial-derived cells by antiviral CD8(+) T cells is entirely perforin-independent. This activity is mediated exclusively by TNF-alpha. Both alveolar epithelial-derived cells and primary murine type II cells show susceptibility to apoptosis triggered by soluble TNF-alpha, without the need for transcriptional or translational inhibition. We also confirmed the resistance of alveolar type II cells to Fast in vivo by performing adoptive transfer of perforin-deficient antiviral CD8(+) T cells into transgenic mice expressing a target antigen in type Il epithelial cells. Significant lung injury developed in the transgenic CD8(+) T-cell recipients, whether or not Fas was expressed in these animals. Furthermore, preincubation of the T cells with antibody to TNF-alpha completely abolished the injury. These results suggest that alveolar epithelial cells are relatively sensitive to T cell-triggered, TNF-alpha-mediated apoptosis, and resistant to apoptosis triggered by Fast. These observations may have important ramifications for understanding of the pathophysiology of interstitial and inflammatory lung diseases.
引用
收藏
页码:849 / 858
页数:10
相关论文
共 50 条
  • [31] Susceptibility to Fas and tumor necrosis factor-α receptor mediated apoptosis of anti-CD3/anti-CD28-activated umbilical cord blood T cells
    Lin, Syh-Jae
    Lee, Chen-Cheng
    Cheng, Po-Jen
    See, Lai-Chu
    Kuo, Ming-Ling
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2009, 20 (04) : 392 - 398
  • [32] Synergistic Enhancement of CD8+ T Cell-Mediated Tumor Vaccine Efficacy by an Anti-Transforming Growth Factor-β Monoclonal Antibody
    Terabe, Masaki
    Ambrosino, Elena
    Takaku, Shun
    O'Konek, Jessica J.
    Venzon, David
    Lonnin, Scott
    McPherson, John M.
    Berzofsky, Jay A.
    CLINICAL CANCER RESEARCH, 2009, 15 (21) : 6560 - 6569
  • [33] Expression of perforin- and Fas ligand-mediated cytolytic activity by CD8 T cells during listeria monocytogenes infections.
    Cousens, LP
    Wing, EJ
    Liu, CC
    Gregory, SH
    FASEB JOURNAL, 2001, 15 (05): : A1027 - A1027
  • [34] Tumor-infiltrating macrophages induce apoptosis in activated CD8+T cells by a mechanism requiring cell contact and mediated by the cell-associated form of tumor necrosis factor-α
    Frey, AB
    Saio, M
    Radoja, S
    FASEB JOURNAL, 2001, 15 (05): : A1203 - A1203
  • [35] ADAM17-Mediated Processing of TNF-α Expressed by Antiviral Effector CD8+ T Cells Is Required for Severe T-Cell-Mediated Lung Injury
    DeBerge, Matthew P.
    Ely, Kenneth H.
    Cheng, Guang-Shing
    Enelow, Richard I.
    PLOS ONE, 2013, 8 (11):
  • [36] Fas-FasL interaction in cytotoxic T cell-mediated vitiligo: The role of lesional expression of tumor necrosis factor-α and interferon-γ in Fas-mediated melanocyte apoptosis
    Jimbo, Haruki
    Nagai, Hiroshi
    Fujiwara, Susumu
    Shimoura, Noriko
    Nishigori, Chikako
    EXPERIMENTAL DERMATOLOGY, 2020, 29 (01) : 61 - 70
  • [37] CD4+ T cells regulate CD8+ T cell-mediated cutaneous immune responses by restricting effector T cell development through a Fas ligand-dependent mechanism
    Gorbachev, AV
    Fairchild, RL
    JOURNAL OF IMMUNOLOGY, 2004, 172 (04): : 2286 - 2295
  • [38] ROLE OF CD8+ CYTOTOXIC T-CELL SURFACE MOLECULES IN T-CELL-MEDIATED DESTRUCTION OF PANCREATIC BETA-CELLS IN NOD MICE
    PARK, BJ
    SANTAMARIA, P
    UTSUGI, T
    KAWAZU, S
    YOON, JW
    DIABETES, 1995, 44 : A139 - A139
  • [39] CD8+ T-cell-mediated killing of donor dendritic cells prevents alloreactive T helper type-2 responses in vivo
    Laffont, Sophie
    Coudert, Jerome D.
    Garidou, Lucile
    Delpy, Laurent
    Wiedemann, Aurelie
    Demur, Cecile
    Coureau, Christiane
    Guery, Jean-Charles
    BLOOD, 2006, 108 (07) : 2257 - 2264
  • [40] CD8 Co-receptor promotes susceptibility of CD8+ T cells to transforming growth factor-β (TGF-β)-mediated suppression
    Zloza, Andrew
    Jagoda, Michael C.
    Lyons, Gretchen E.
    Graves, Michael C.
    Kohlhapp, Frederick J.
    O'Sullivan, Jeremy A.
    Lacek, Andrew T.
    Nishimura, Michael I.
    Guevara-Patino, Jose A.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (02) : 291 - 297